Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Recursion Pharmaceuticals

< Previous 1 2 3 Next >
News headline image
Recursion Reports Third Quarter 2026 Financial Results and Extends Cash Runway; Highlights Positive Clinical Data in REC-4881 and REC-1245, Sanofi Development Candidate Option and Appointment of Fred Hassan as Chair
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
New Phase 2 REC-4881 Data Presented at CGA-IGC Show Deep, Durable Polyp Burden Reductions in FAP, with Activity Across the GI Tract and in Larger, Higher-Risk Polyps
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Appoints Fred Hassan as Chair of the Board
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion to Host Webinar Focused on Updated REC-4881 (FAP) Data from CGA-IGC on Tuesday, November 3
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Announces Sanofi Options Potential First-in-Class Immunology Development Candidate from Their Collaboration
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion to Participate in Upcoming Investor Conferences
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Announces Pricing of $200 Million Underwritten Offering of Class A Common Stock
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion to Report Second Quarter 2026 Business Updates and Financial Results on August 5th
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion to Participate in Upcoming Investor Conferences
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Reports First Quarter Financial Results and Provides Business Update
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Announces Board Transition
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion to Report First Quarter 2026 Business Updates and Financial Results on May 6
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion to Participate in Upcoming Investor Conferences
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion To Be Featured in HighRes’ Lightning Talk at NVIDIA GTC
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion to Participate in Upcoming Investor Conferences
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion to Report Fourth Quarter and Full Year 2025 Business Updates and Financial Results on February 25
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion to Present at 44th Annual J.P. Morgan Healthcare Conference
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Announces Webinar For Upcoming Clinical Data Readout on the TUPELO Phase 1b/2 Trial of REC-4881 in Familial Adenomatous Polyposis on December 8, 2025
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Announces CEO Transition Plan to Drive Next Phase of Growth
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion to Participate in Upcoming Investor Conferences
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion to Participate in Upcoming Investor Conferences
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
News headline image
Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update
From Recursion Pharmaceuticals
Via GlobeNewswire
Tickers RXRX
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.